Evidence map›Paper›PMID 24803171›Full record

ArticleChemical biology & drug design2014

Hapten optimization for cocaine vaccine with improved cocaine recognition.

Muthu Ramakrishnan, Berma M Kinsey, Rana A Singh, Thomas R Kosten, Frank M Orson

Open access · bronzeAbstract read
In one paragraph

Article in Chemical biology & drug design, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
2.2field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 18 citations in OpenAlex.

  1. Calix[Journal of advanced research · 2022
    Article
  2. Review
  3. Investigations into the efficacy of multi-component cocaine vaccines.Bioorganic & medicinal chemistry letters · 2018
    Article
  4. Article
  5. Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Muthu RamakrishnanMichael E. DeBakey Veterans Affairs Medical Center, Baylor College of Medicine, Houston, 77030, TX, USA; Department of Medicine and Clinical Immunology, Baylor College of Medicine, Houston, 77030, TX, USA.
Berma M Kinsey
Rana A Singh
Thomas R Kosten
Frank M Orson
Baylor College of Medicine · US

Funding

Human methamphetamine vaccine: Translational Avante Garde AwardDP1DA033502 · NIDA · BAYLOR COLLEGE OF MEDICINE · PI KOSTEN, THOMAS RICHARD · 2011 to 2015
$4.0M
Development of Novel Vaccines for Cocaine AbuseR01DA030338 · NIDA · METHODIST HOSPITAL RESEARCH INSTITUTE · PI ORSON, FRANK M, WANG, RONGFU · 2010 to 2014
$1.6M
Developing Immunotherapeutics for Methamphetamine AbuseU01DA023898 · NIDA · BAYLOR COLLEGE OF MEDICINE · PI ORSON, FRANK M · 2009 to 2010
$1.4M
Cocaine Vaccines: Antibody and Affinity Measurement in SerumR21DA035591 · NIDA · BAYLOR COLLEGE OF MEDICINE · PI MUTHU, RAMAKRISHNAN · 2013 to 2014
$391k
NIDA NIH HHS DP1 DA033502NIDA NIH HHS R01 DA030338NIDA NIH HHS R21 DA035591NIDA NIH HHS U01 DA023898
6 · The paper itself

Abstract

In the absence of any effective pharmacotherapy for cocaine addiction, immunotherapy is being actively pursued as a therapeutic intervention. While several different cocaine haptens have been explored to develop anticocaine antibodies, none of the hapten was successfully designed, which had a protonated tropane nitrogen as is found in native cocaine under physiological conditions, including the succinyl norcocaine (SNC) hapten that has been tested in phase II clinical trials. Herein, we discuss three different cocaine haptens: hexyl norcocaine (HNC), bromoacetamido butyl norcocaine (BNC), and succinyl butyl norcocaine (SBNC), each with a tertiary nitrogen structure mimicking that of native cocaine which could optimize the specificity of anticocaine antibodies for better cocaine recognition. Mice immunized with these haptens conjugated to immunogenic proteins produced high titre anticocaine antibodies. However, during chemical conjugation of HNC and BNC haptens to carrier proteins, the 2β methyl ester group is hydrolyzed, and immunizing mice with these conjugate vaccines in mice produced antibodies that bound both cocaine and the inactive benzoylecgonine metabolite. While in the case of the SBNC conjugate, vaccine hydrolysis of the methyl ester did not appear to occur, leading to antibodies with high specificity to cocaine over BE. Although we observed similar specificity with a SNC hapten, the striking difference is that SBNC carries a positive charge on the tropane nitrogen atom, and therefore, it is expected to have better binding of cocaine. The 50% cocaine inhibitory concentration (IC50 ) value for SBNC antibodies (2.8 μm) was significantly better than the SNC antibodies (9.4 μm) when respective hapten-BSA was used as a substrate. In addition, antibodies from both sera had no inhibitory effect from BE. In contrast to BNC and HNC, the SBNC conjugate was also found to be highly stable without any noticeable hydrolysis for several months at 4 °C and 2-3 days in pH 10 buffer at 37 °C.

Indexed as

AnimalsAntibodiesCocaineEnzyme-Linked Immunosorbent AssayHaptensMaleMiceMice, Inbred BALB CVaccinesAntibodiesCocaineHaptensnorcocaineVaccinesaddictionantibodybenzoylecgoninecarrier proteincocainehaptenmiceouter membrane protein complexspecificitysubstance abuseTA-CD vaccinevaccine

Identifiers

PMID24803171
PMCPMC4127111
OpenAlexW1969852052

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.